Endoscopy 2021; 53(01): 65-71
DOI: 10.1055/a-1197-6762
Original article

Implementation of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) sedation training course in a regular endoscopy unit

Mauro Manno
1   Gastroenterology and Digestive Endoscopy Unit, Azienda USL Modena, Carpi, Italy
,
Simona Deiana
1   Gastroenterology and Digestive Endoscopy Unit, Azienda USL Modena, Carpi, Italy
,
Tommaso Gabbani
1   Gastroenterology and Digestive Endoscopy Unit, Azienda USL Modena, Carpi, Italy
,
Matteo Gazzi
2   Anesthesiology and Intensive Care Unit, Azienda USL Modena, Carpi, Italy
,
Alessandro Pignatti
2   Anesthesiology and Intensive Care Unit, Azienda USL Modena, Carpi, Italy
,
Enrica Becchi
2   Anesthesiology and Intensive Care Unit, Azienda USL Modena, Carpi, Italy
,
Laura Ottaviani
1   Gastroenterology and Digestive Endoscopy Unit, Azienda USL Modena, Carpi, Italy
,
Sara Vavassori
1   Gastroenterology and Digestive Endoscopy Unit, Azienda USL Modena, Carpi, Italy
,
Elis Sacchi
2   Anesthesiology and Intensive Care Unit, Azienda USL Modena, Carpi, Italy
,
Cesare Hassan
3   Gastroenterology and Endoscopy Unit, Nuovo Ospedale Regina Margerita, Rome, Italy
,
Paola Soriani
1   Gastroenterology and Digestive Endoscopy Unit, Azienda USL Modena, Carpi, Italy
› Institutsangaben

Abstract

Background Several scientific societies have endorsed non-anesthesiologist sedation (NAS) during gastrointestinal endoscopy, considering it a safe procedure when administered by adequately trained personnel. This study aimed to evaluate the occurrence of adverse events after implementation of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) sedation training program.

Methods From January 2017 to August 2018, data from all consecutive endoscopic procedures in adults (≥ 18 years) performed at our endoscopy unit were collected using an electronic reporting system.

Results All staff (physicians and nurses) completed the ESGE-ESGENA sedation course. In total, 12 132 patients underwent endoscopic procedures, 10 755 (88.6 %) of which were performed in a non-anesthesiological setting. Of these, about 20 % used moderate sedation with midazolam + fentanyl and 80 % used deep sedation with additional propofol. No sentinel, 5 (0.05 %) moderate risk, and 18 (0.17 %) minor risk adverse events occurred, all during moderate or deep sedation, and all managed by endoscopy staff without the need for anesthesiologist assistance.

Conclusions After completing the ESGE-ESGENA sedation training program, the rate of adverse events was very low in our institution. The findings support implementation of the program in all digestive endoscopy units and inclusion in the curriculum for physicians and nurses to ensure safe endoscopic procedures.



Publikationsverlauf

Eingereicht: 20. Januar 2020

Angenommen: 14. Mai 2020

Artikel online veröffentlicht:
25. Juni 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Lee TJ, Rutter MD, Blanks RG. et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012; 61: 1050-1057
  • 2 Dumonceau JM, Riphaus A, Schreiber F. et al. Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline – updated June 2015. Endoscopy 2015; 47: 1175-1189
  • 3 Early DS, Lightdale JR, Vargo JJ. et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2018; 87: 327-337
  • 4 Conigliaro R, Fanti L, Manno M. et al. Italian Society of Digestive Endoscopy (SIED) position paper on the non-anaesthesiologist administration of propofol for gastrointestinal endoscopy. Dig Liver Dis 2017; 49: 1185-1190
  • 5 Cohen LB, Hightower CD, Wood DA. et al. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc 2004; 59: 795-803
  • 6 Rex DK, Deenadayalu VP, Eid E. et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology 2009; 137: 1229-1237
  • 7 Dumonceau JM, Riphaus A, Beilenhoff U. et al. European curriculum for sedation training in gastrointestinal endoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA). Endoscopy 2013; 45: 496-504
  • 8 American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002; 96: 1004-1017
  • 9 Mason KP, Green SM. Piacevoli Q el al. Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: a consensus document from the World SIVA International Sedation Task Force. Br J Anaesth 2012; 108: 13-20
  • 10 Chernik DA, Gillings D, Laine H. et al. Validity and reliability of the observer’s assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 1990; 10: 244-251
  • 11 Ferreira AO, Torres J, Barjas E. et al. Non-anaesthesiologist administration of propofol sedation for colonoscopy is safe in low risk patients: results of a non-inferiority randomized controlled trial. Endoscopy 2016; 48: 747-753
  • 12 Bannert C, Reinhart K, Dunkler D. et al. Sedation in screening colonoscopy: impact on quality indicators and complications. Am J Gastroenterol 2012; 107: 1837-1848
  • 13 Hassan C, Rex D, Cooper GS. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis. Endoscopy 2012; 44: 456-464